Offshore
Photo
Hidden Value Gems
Another piece on the divergence of US and EU stocks. by a GS PM.
Some reasons for lower valuation of EU/UK stocks (higher energy costs, war, higher exposure to China, sector composition) don't fully explain the valuation gap.
The options EU/UK companies could consider...👇🏽
1/5 https://t.co/8zxguVuMWj
tweet
Another piece on the divergence of US and EU stocks. by a GS PM.
Some reasons for lower valuation of EU/UK stocks (higher energy costs, war, higher exposure to China, sector composition) don't fully explain the valuation gap.
The options EU/UK companies could consider...👇🏽
1/5 https://t.co/8zxguVuMWj
tweet
Offshore
Photo
Brandon Beylo
The one benefit of not sleeping due to a newborn is that you can check tin prices before most of your commodity degenerate friends are awake.
Up another 6% this morning.
Good Lord.
#tin https://t.co/18PmmJEc9m
tweet
The one benefit of not sleeping due to a newborn is that you can check tin prices before most of your commodity degenerate friends are awake.
Up another 6% this morning.
Good Lord.
#tin https://t.co/18PmmJEc9m
#Tin price: 31665 (+1,817, +6.09%)
7:42am London $Tin https://t.co/bAY5wJPYfN - Tin Bottweet
Brandon Beylo
Breaking from @Sino_Market:
“The Shanghai Futures Exchange has imposed transaction limits on #gold and #copper futures to control recent trading price risks.
The daily opening position limit has been set at 2,800 lots for gold and 2,000 lots for copper.”
Probably nothing.
tweet
Breaking from @Sino_Market:
“The Shanghai Futures Exchange has imposed transaction limits on #gold and #copper futures to control recent trading price risks.
The daily opening position limit has been set at 2,800 lots for gold and 2,000 lots for copper.”
Probably nothing.
tweet
Offshore
Photo
Brandon Beylo
Yes, gold is at all-time highs.
And yes, it's extremely overextended across multiple time frames.
But look at this $GLD fund flow chart below.
We are not even close to a parabolic move in gold.
#gold https://t.co/RioPk0MoA7
tweet
Yes, gold is at all-time highs.
And yes, it's extremely overextended across multiple time frames.
But look at this $GLD fund flow chart below.
We are not even close to a parabolic move in gold.
#gold https://t.co/RioPk0MoA7
tweet
Offshore
Photo
Antonio Linares
$TSLA is crafting a platform comparable to the internet, poised at a breakthrough point that will overshadow previous milestones.
Tesla's swiftly advancing manufacturing abilities are propelling its foray into AI and energy sectors.
Together, these sectors are poised to forge a platform that mirrors the internet—automating manual labor globally through scalable autonomous robotics.
This harmonious ecosystem capitalizes on their primary expertise: optimizing unit economics more rapidly than competitors.
Despite a declining stock price, $TSLA's manufacturing prowess continues to improve quietly. This is evidenced by the rapidly rising FCF/ Op. Margin metric, which so few truly understand.
Over time, refined manufacturing means enhanced production of batteries, solar panels, and vehicles, which in turn boosts data accumulation for their Full Self-Driving (FSD) technology.
With increased data, $TSLA’s AI grows exponentially smarter.
Two pivotal metrics highlight significant advancements:
1. Total FSD miles driven: A substantial rise over the last two years.
2. Energy storage deployment: Surging by 222% YoY, driven by increased energy demand and cost-effective Tesla batteries.
Though the automotive market faces challenges with rising interest rates, Tesla's manufacturing advancements are set to exponentially elevate its AI and energy segments.
This trajectory sets the stage for autonomous robots that produce their own energy, potentially transforming the global economy.
While the feasibility of these ambitions is yet to be determined, I’m holding onto my shares. Despite current economic pressures making cars less affordable, Tesla’s long-term potential shines brightly.
tweet
$TSLA is crafting a platform comparable to the internet, poised at a breakthrough point that will overshadow previous milestones.
Tesla's swiftly advancing manufacturing abilities are propelling its foray into AI and energy sectors.
Together, these sectors are poised to forge a platform that mirrors the internet—automating manual labor globally through scalable autonomous robotics.
This harmonious ecosystem capitalizes on their primary expertise: optimizing unit economics more rapidly than competitors.
Despite a declining stock price, $TSLA's manufacturing prowess continues to improve quietly. This is evidenced by the rapidly rising FCF/ Op. Margin metric, which so few truly understand.
Over time, refined manufacturing means enhanced production of batteries, solar panels, and vehicles, which in turn boosts data accumulation for their Full Self-Driving (FSD) technology.
With increased data, $TSLA’s AI grows exponentially smarter.
Two pivotal metrics highlight significant advancements:
1. Total FSD miles driven: A substantial rise over the last two years.
2. Energy storage deployment: Surging by 222% YoY, driven by increased energy demand and cost-effective Tesla batteries.
Though the automotive market faces challenges with rising interest rates, Tesla's manufacturing advancements are set to exponentially elevate its AI and energy segments.
This trajectory sets the stage for autonomous robots that produce their own energy, potentially transforming the global economy.
While the feasibility of these ambitions is yet to be determined, I’m holding onto my shares. Despite current economic pressures making cars less affordable, Tesla’s long-term potential shines brightly.
tweet
Offshore
Photo
The Long Investor
RT @TheLongInvest: $DAL
A reminder that $DAL is a Buy by 20 analysts, 100% Buy rating.
The price is also below the lowest PT at $47
With the highest PT at $77
TLI PT is $64 https://t.co/ViwMVKzVbp
tweet
RT @TheLongInvest: $DAL
A reminder that $DAL is a Buy by 20 analysts, 100% Buy rating.
The price is also below the lowest PT at $47
With the highest PT at $77
TLI PT is $64 https://t.co/ViwMVKzVbp
tweet
Offshore
Photo
The Long Investor
RT @DailyCompoundng: Jack Ma: “The $BABA group has returned to the path of profitable growth and the AI era has just arrived” 🔥 https://t.co/WMRZBNDCUT
tweet
RT @DailyCompoundng: Jack Ma: “The $BABA group has returned to the path of profitable growth and the AI era has just arrived” 🔥 https://t.co/WMRZBNDCUT
tweet
Offshore
Photo
The Long Investor
RT @stocktalkweekly: DELTA AIRLINES EARNINGS $DAL
Q1 EPS: $0.45 v $0.36 est.
Q1 Revenue: $13.75B vs. $12.57B est.
Q2 EPS Guide: $2.20 - $2.50 vs. $2.23 est.
FY EPS: $6 - $7 vs. $6.46 est.
Delta sees strong demand to carry into June. CEO says "no letup in demand", corporate travel accelerating.
tweet
RT @stocktalkweekly: DELTA AIRLINES EARNINGS $DAL
Q1 EPS: $0.45 v $0.36 est.
Q1 Revenue: $13.75B vs. $12.57B est.
Q2 EPS Guide: $2.20 - $2.50 vs. $2.23 est.
FY EPS: $6 - $7 vs. $6.46 est.
Delta sees strong demand to carry into June. CEO says "no letup in demand", corporate travel accelerating.
tweet
Offshore
Photo
Antonio Linares
$HIMS has great potential to go 100X from here.
$HIMS operates as a telehealth enterprise, facilitating connections between patients and doctors through a digital app, while also managing medication dispensation through advanced automated pharmacy systems.
Here are the six principal value drivers for the company:
1. Cost Efficiency: $HIMS offers treatments for a widening array of conditions at prices lower than typical out-of-pocket costs through insurance, creating a formidable economic barrier in a sector known for cost pressures.
2. Growth in Service Range: Each quarter sees $HIMS addressing an increasing number of medical conditions. The company's leadership continues to select new service areas judiciously, enhancing operational cash flow.
3. Exceptional Organizational Capabilities: $HIMS has adeptly built an integrated operation combining software (the app) and hardware (pharmacies), navigating the challenging healthcare sector. For example, within just two years of its release, the $HIMS iOS app has climbed to the 16th position in U.S. healthcare app rankings—a testament to organizational excellence.
4. AI-Enhanced Decisions: $HIMS stands out as the pioneer in employing AI in a closed-loop system within healthcare, uniquely using data insights to refine healthcare frameworks continuously. This innovative approach positions $HIMS to outpace competitors over time.
5. Increased Personalization: As $HIMS expands its range of conditions treated, it will see reduced customer acquisition costs and enhanced lifetime value. This evolution toward personalized treatment will make $HIMS more indispensable to its users, encouraging longer engagement with the platform.
6. Enhanced Operating Leverage: With the expansion of service areas and the refinement of its automated pharmacy processes, $HIMS's high degree of personalization will become increasingly difficult to replicate on a large scale. This is expected to lead to better unit economics, contributing to a stronger cash flow profile moving forward.
See $HIMS cash from operations👇
tweet
$HIMS has great potential to go 100X from here.
$HIMS operates as a telehealth enterprise, facilitating connections between patients and doctors through a digital app, while also managing medication dispensation through advanced automated pharmacy systems.
Here are the six principal value drivers for the company:
1. Cost Efficiency: $HIMS offers treatments for a widening array of conditions at prices lower than typical out-of-pocket costs through insurance, creating a formidable economic barrier in a sector known for cost pressures.
2. Growth in Service Range: Each quarter sees $HIMS addressing an increasing number of medical conditions. The company's leadership continues to select new service areas judiciously, enhancing operational cash flow.
3. Exceptional Organizational Capabilities: $HIMS has adeptly built an integrated operation combining software (the app) and hardware (pharmacies), navigating the challenging healthcare sector. For example, within just two years of its release, the $HIMS iOS app has climbed to the 16th position in U.S. healthcare app rankings—a testament to organizational excellence.
4. AI-Enhanced Decisions: $HIMS stands out as the pioneer in employing AI in a closed-loop system within healthcare, uniquely using data insights to refine healthcare frameworks continuously. This innovative approach positions $HIMS to outpace competitors over time.
5. Increased Personalization: As $HIMS expands its range of conditions treated, it will see reduced customer acquisition costs and enhanced lifetime value. This evolution toward personalized treatment will make $HIMS more indispensable to its users, encouraging longer engagement with the platform.
6. Enhanced Operating Leverage: With the expansion of service areas and the refinement of its automated pharmacy processes, $HIMS's high degree of personalization will become increasingly difficult to replicate on a large scale. This is expected to lead to better unit economics, contributing to a stronger cash flow profile moving forward.
See $HIMS cash from operations👇
tweet
The Long Investor
US CPI data released, and it's hotter than expected
- US CPI YoY Actual 3.5% (Forecast 3.4%, Previous 3.2%)
- US Core CPI YoY Actual 3.8% (Forecast 3.7%, Previous 3.8%)
- US CPI MoM Actual 0.4% (Forecast 0.3%, Previous 0.4%)
- US Core CPI MoM Actual 0.4% (Forecast 0.3%, Previous 0.4%)
tweet
US CPI data released, and it's hotter than expected
- US CPI YoY Actual 3.5% (Forecast 3.4%, Previous 3.2%)
- US Core CPI YoY Actual 3.8% (Forecast 3.7%, Previous 3.8%)
- US CPI MoM Actual 0.4% (Forecast 0.3%, Previous 0.4%)
- US Core CPI MoM Actual 0.4% (Forecast 0.3%, Previous 0.4%)
tweet